Fludarabine phosphate

Download report

Favorite

Events Timeline

Commercial

Clinical

Drug

Target

Variants

Financial

Trends

Safety

Events Timeline

YTD

Max

Events

FDA approval date

EMA approval date

Patent expiration date

Study first post date

Last update post date

Start date

Primary completion date

Completion date

Results first post date

Mock data
Subscribe for the real data

Commercial

No data

Clinical

Clinical Trials

2232 clinical trials

Mock data
Subscribe for the real data

Indications Phases 4

Indication	MeSH	Ontology	ICD-10	Ph 1	Ph 2	Ph 3	Ph 4	Other	Total
Leukemia	D007938	—	C95	396	535	97	16	58	932
Lymphoma	D008223	—	C85.9	272	306	35	2	37	560
Myeloid leukemia acute	D015470	—	C92.0	174	241	56	6	26	432
Myeloid leukemia	D007951	—	C92	161	237	45	5	24	402
Lymphoid leukemia	D007945	—	C91	175	213	43	8	20	390
Myelodysplastic syndromes	D009190	—	D46	123	253	24	2	29	379
Precursor cell lymphoblastic leukemia-lymphoma	D054198	—	—	171	185	19	5	22	341
B-cell chronic lymphocytic leukemia	D015451	—	C91.1	117	178	36	3	15	303
Non-hodgkin lymphoma	D008228	—	C85.9	152	159	15	1	20	290
Preleukemia	D011289	—	—	91	177	14	2	19	265

Show 11 more

Indications Phases 3

Indication	MeSH	Ontology	ICD-10	Ph 1	Ph 2	Ph 3	Ph 4	Other	Total
Neoplasms	D009369	—	C80	181	141	5	—	16	288
B-cell lymphoma	D016393	—	—	130	79	5	—	11	191
Hematologic neoplasms	D019337	—	—	76	114	3	—	19	182
Plasma cell neoplasms	D054219	—	—	91	76	9	—	15	171
Bcr-abl positive chronic myelogenous leukemia	D015464	EFO_0000340	—	31	107	7	—	11	138
Hodgkin disease	D006689	—	C81	44	80	3	—	13	122
Melanoma	D008545	—	—	53	63	1	—	2	101
Large b-cell lymphoma diffuse	D016403	—	C83.3	58	49	4	—	5	100
Follicular lymphoma	D008224	—	C82	38	54	12	—	5	98
Mantle-cell lymphoma	D020522	—	—	41	53	9	—	6	93

Show 47 more

Indications Phases 2

Indication	MeSH	Ontology	ICD-10	Ph 1	Ph 2	Ph 3	Ph 4	Other	Total
Carcinoma	D002277	—	C80.0	57	26	—	—	4	70
T-cell lymphoma	D016399	—	—	25	32	—	—	5	55
Ovarian neoplasms	D010051	EFO_0003893	C56	43	22	—	—	—	53
Plasmacytoma	D010954	—	C90.3	14	30	—	—	9	49
Breast neoplasms	D001943	EFO_0003869	C50	34	25	—	—	—	46
Renal cell carcinoma	D002292	EFO_0000376	—	27	22	—	—	3	41
Precursor t-cell lymphoblastic leukemia-lymphoma	D054218	—	—	34	15	—	—	—	37
Biphenotypic leukemia acute	D015456	—	C95.0	19	21	—	—	—	36
Hematologic diseases	D006402	EFO_0005803	D75.9	8	21	—	—	9	35
T-cell lymphoma peripheral	D016411	—	—	17	20	—	—	4	35

Show 273 more

Indications Phases 1

Indication	MeSH	Ontology	ICD-10	Ph 1	Ph 2	Ph 3	Ph 4	Other	Total
Rhabdoid tumor	D018335	—	—	4	—	—	—	—	4
Female genital neoplasms	D005833	—	—	4	—	—	—	—	4
Small cell lung carcinoma	D055752	—	—	3	—	—	—	—	3
Wilms tumor	D009396	EFO_0000212	—	3	—	—	—	—	3
Nervous system diseases	D009422	—	G00-G99	3	—	—	—	—	3
Autoimmune diseases of the nervous system	D020274	—	—	3	—	—	—	—	3
Ependymoma	D004806	—	—	2	—	—	—	—	2
Gastrointestinal stromal tumors	D046152	EFO_0000505	C49.A	2	—	—	—	—	2
Adrenocortical carcinoma	D018268	—	—	2	—	—	—	—	2
Aids-related lymphoma	D016483	EFO_1001365	—	1	—	—	—	1	2

Show 53 more

Indications Without Phase

Indication	MeSH	Ontology	ICD-10	Ph 1	Ph 2	Ph 3	Ph 4	Other	Total
Abnormal karyotype	D059786	—	—	—	—	—	—	1	1
Hemoglobin c disease	D006445	—	D58.2	—	—	—	—	1	1
Type 1 hyper-igm immunodeficiency syndrome	D053307	—	—	—	—	—	—	1	1
Hereditary congenital and neonatal diseases and abnormalities	D009358	—	—	—	—	—	—	1	1
Primary graft dysfunction	D055031	—	—	—	—	—	—	1	1
Antiphospholipid syndrome	D016736	EFO_0002689	D68.61	—	—	—	—	1	1